RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 23-33
  • GlaxoSmithKline launches probe into claims of misconduct in Iraq

    GlaxoSmithKline launches probe into claims of misconduct in Iraq
    British drug-maker GlaxoSmithKline said it is launching an investigation into claims of misconduct in Iraq. The announcement comes months after China began looking into allegations of a bribery ring within the company's business in that country. The...
  • A new era of testing [Commentary]

    A new era of testing [Commentary]
    Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits. The presence of these...
  • Televised confessions in China raise worries

    Televised confessions in China raise worries
    BEIJING — The headline news on state-run Chinese Channel 13 was juicy: A mining tycoon and 35 others had been charged with running a mafia-style enterprise in Sichuan province, gunning down enemies in the street, bribing people and operating an...
  • CVS' halt on tobacco wins praise

    CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...
  • Former head of GlaxoSmithKline in China is accused of bribery

    Former head of GlaxoSmithKline in China is accused of bribery
    The former head of GlaxoSmithKline in China was charged with corruption by local authorities after a probe that resulted in accusations that the drug maker ran a wide-ranging bribery scheme that included payoffs to doctors. Chinese police alleged that...
  • Glaxo to stop paying doctors to promote its drugs

    Glaxo to stop paying doctors to promote its drugs
    Ending a practice that some say creates a conflict of interest, British pharmaceutical company GlaxoSmithKline said Tuesday it would end its practice of paying doctors to promote its drugs. Glaxo, maker of drugs such as the antidepressant Paxil, also...
  • Chinese dissident, in TV shaming, apologizes for spilling secrets

    Chinese dissident, in TV shaming, apologizes for spilling secrets
    One of China’s most venerable dissident journalists was paraded  on state television Thursday morning, apologizing for spilling state secrets that embarrassed the Chinese Communist Party. The public shaming of Gao Yu, a 70-year-old grandmother who...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Illinois among 45 states settling off-label dispute with GlaxoSmithKline

    Illinois among 45 states settling off-label dispute with GlaxoSmithKline
    The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....
  • The week in review: scams, refunds, recalls and other consumer news you need to know

     
    Happy Monday! If you're looking for good news, you've come to the wrong place. If you want the dirt on the latest scams, accusations of fraud, recalls and other consumer news, read on for a summary of what the Watchdog......
  • Nuevo rival para el Viagra

    Nuevo rival para el Viagra
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...